Digilib Perpustakaan Universitas Riau

Tugas Akhir, Skripsi, Tesis dan Disertasi Mahasiswa Universitas Riau

  • Beranda
  • Informasi
  • Berita
  • Bantuan
  • Pustakawan
  • Pilih Bahasa :
    Bahasa Arab Bahasa Bengal Bahasa Brazil Portugis Bahasa Inggris Bahasa Spanyol Bahasa Jerman Bahasa Indonesia Bahasa Jepang Bahasa Melayu Bahasa Persia Bahasa Rusia Bahasa Thailand Bahasa Turki Bahasa Urdu

Pencarian berdasarkan :

SEMUA Pengarang Subjek ISBN/ISSN Pencarian Spesifik

Pencarian terakhir:

{{tmpObj[k].text}}
Image of Kepentingan India Menolak Permohonan Hak Paten Obat Kanker Dari Perusahaan Novartis Negara Swiss
Penanda Bagikan

CD Skripsi

Kepentingan India Menolak Permohonan Hak Paten Obat Kanker Dari Perusahaan Novartis Negara Swiss

YUYUN SYAPUTRI / 1301120272 - Nama Orang;

This study is an international political economy study explaining about India's interest in applying protection policy to its pharmaceutical industry. India's protective form is to include article 3 (d) in the 2005 amendment as a reference. This study is interesting because it describes the generics and patents. India is the third largest country in the production of generic drugs. India can do that after they make some revolutions in Indian intellectual property law.
This research uses explanatory research methods, and collects data from several sources such as books, journals, official publications and relevant websites. This research uses the perspective of mercantilism, in this perspective the State becomes the main actor who actively and rationally organizes the economy in order to increase the power and power of the State. The level of analysis used in this study is the nation state. This study also uses the theory of protectionism which is the state's efforts to protect the interests of the country, focusing on the economy internationally.
The results of this study indicate that India rejected the application of Patent for cancer drugs proposed by Novartis will disrupt India's pharmaceutical industry is able to grow very rapidly to become the largest producer of generic drugs in the world. And filing a patent for cancer drug (Glivec) by a Novartis that worries India. Therefore, India tries to protect its pharmaceutical industry under article 3 (d) of the 2005 amendment law.
Keywords: Patent rights, Pharmaceutical industry, India, Protection, Generic drugs


Ketersediaan
#
Perpustakaan Universitas Riau 01 01. 118 (0032)
01 01. 118 (0032)
Tersedia
Informasi Detail
Judul Seri
-
No. Panggil
01 01. 118 (0032)
Penerbit
Pekanbaru : Universitas Riau – Fakultas Ilmu Sosial Dan Ilmu Politik – Ilmu Hubungan Internasional., 2018
Deskripsi Fisik
x, 49 hlm.; ill.; 29 cm
Bahasa
Indonesia
ISBN/ISSN
-
Klasifikasi
01 01. 118 (0032)
Tipe Isi
-
Tipe Media
-
Tipe Pembawa
-
Edisi
-
Subjek
ILMU HUBUNGAN INTERNASIONAL
Info Detail Spesifik
-
Pernyataan Tanggungjawab
DAUS
Versi lain/terkait

Tidak tersedia versi lain

Lampiran Berkas
  • JUDUL
  • ABSTRAK
  • DAFTAR ISI
  • BAB I PENDAHULUAN
  • BAB II GAMBARAN UMUM
  • BAB III METODE PENELITIAN
  • BAB IV HASIL DAN PEMBAHASAN PENELITIAN
  • BAB V KESIMPULAN
  • DAFTAR PUSTAKA
  • LAMPIRAN
Komentar

Anda harus masuk sebelum memberikan komentar

Digilib Perpustakaan Universitas Riau
  • Informasi
  • Layanan
  • Pustakawan
  • Area Anggota

Tentang Kami

As a complete Library Management System, SLiMS (Senayan Library Management System) has many features that will help libraries and librarians to do their job easily and quickly. Follow this link to show some features provided by SLiMS.

Cari

masukkan satu atau lebih kata kunci dari judul, pengarang, atau subjek

Donasi untuk SLiMS Kontribusi untuk SLiMS?

© 2025 — Senayan Developer Community

Ditenagai oleh SLiMS
Pilih subjek yang menarik bagi Anda
  • Karya Umum
  • Filsafat
  • Agama
  • Ilmu-ilmu Sosial
  • Bahasa
  • Ilmu-ilmu Murni
  • Ilmu-ilmu Terapan
  • Kesenian, Hiburan, dan Olahraga
  • Kesusastraan
  • Geografi dan Sejarah
Icons made by Freepik from www.flaticon.com
Pencarian Spesifik
Kemana ingin Anda bagikan?